Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Issue of Equity

26th Jul 2007 07:01

International Medical Devices PLC26 July 2007 26 July 2007 International Medical Devices plc ("IMD" or "the Company") Placing to raise £515,300, conversion of £500,000 loan noteand Trading Update International Medical Devices plc, the medical supply company targeting themedical consumables, cardiorespiratory, acute and aged care markets, is pleasedto announce that it today placed 14,132,500 new ordinary shares of 1p each("Placing Shares") at 4p each ("Placing Price") to raise approximately £515,300,before expenses. Of the Placing Shares issued, 1,250,000 were allotted in lieuof bonuses due to certain members of the Board, as detailed below. These shares have been placed with institutional investors, other than 2.25mshares which were subscribed for by the Board and senior management of IMD asdetailed below. A warrant exercisable at 3.5p will be issued for each PlacingShare. These warrants are exercisable for three years and will not betransferable and no application will be made to have the warrants admitted toAIM. In addition, the vendors of Response Medical who hold a loan note of £500,000have agreed to convert the loan note into 12.5m new Ordinary Shares. Warrants,as detailed above, will also be issued in respect of these new Ordinary Shares. Furthermore, the Company has today issued 500,000 shares as final payment inrelation to the acquisition of Meddis Limited. Application will be made for the 27,132,500 new ordinary shares issued to beadmitted to trading on AIM and it is expected that admission will be effectiveand dealings will commence on 1 August 2007. The funds raised will be used to launch the SuretyTM range of safety devices,which includes SuretyTM Needle, the manually retractable hypodermic safetyneedle, referred to during its development phase as 'ClipOn'. The funds willalso be used for the launch of INOGEN One, one of the world's smallest andlightest oxygen concentrators. Of the Placing Shares issued, the following have been placed with Directors and senior management. Director Warrants allotted New Ordinary with Total Shareholding Percentage Shares issued New Ordinary on Admission of enlarged Shares ordinary share capital held Lindsay Sanford 250,000 250,000 3,950,000 1.33Christopher Thomas1 625,000 625,000 2,405,952 0.81Michael Acheson1 625,000 625,000 1,739,285 0.59Matthew Root2 4,250,000 4,250,000 17,450,000 5.90John Butler2 4,000,000 4,000,000 17,200,000 5.81 Total 9,750,000 9,750,000 42,745,237 14.44 Note 1: Included in the above is 625,000 shares for both Christopher Thomas and Michael Acheson which represents bonuses due that are being satisfied by the allotment of new Ordinary Shares at the Placing Price. Note 2: Included in these amounts is 3,750,000 shares each in relation to the conversion of the loan note as detailed above. Trading Update Trading across the group remains in line with the Board's expectations and theseadditional funds will allow IMD to continue with its organic growth. Lindsay Sanford, Chairman said: "IMD continues to deliver on its stated objectives. Our buy and build strategyis delivering a profitable medical device distribution business and these fundswill allow us to continue our rapid development. The prospects for INOGEN Oneand the SuretyTM Safety Devices look very encouraging and the Board looksforward to the future with confidence." For further information, contact: International Medical Devices JM Finn Parkgreen CommunicationsChris Thomas Geoff Nash Simon Robinson/Clare IrvineCEO +44 20 7600 1658 +44 20 7851 7480+44 20 3008 4960 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Intelliam Ai
FTSE 100 Latest
Value10,416.08
Change-36.60